Out of stock

This item is currently unavailable

Gone for 76 days. Could come back at any time — we're watching for you.

Out of stock 76 days

World Outlook: Chemotherapy and Multiple Myeloma (2025-2030)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

View at Amazon ↗
Out of stock

Price data last checked 76 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

No price data available for histogram

Description

Gain a comprehensive understanding of the global market for chemotherapy and other multiple myeloma therapeutics with this detailed study. Covering more than 190 countries, this report provides essential data for industry analysis through the year 2030. Each year reported includes estimates for latent demand, also known as potential industry earnings (P.I.E.), expressed in millions of U.S. dollars. The study provides the percent share for each country relative to its region and the entire globe. These comparative benchmarks allow for quick assessment of a country's market position against others. The data is developed using econometric models that project fundamental economic dynamics within and across individual countries, providing a data-driven view of the therapeutic landscape.

Key Features

Provides a world outlook for chemotherapy and multiple myeloma therapeutics through 2030.

Includes data covering more than 190 countries for global market coverage.

Offers latent demand estimates, or potential industry earnings (P.I.E.), in millions of U.S. dollars.

Delivers comparative benchmarks by showing each country's percent share of its region and the globe.

Utilizes econometric models to project fundamental economic dynamics across different countries.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
03 May 2024

Similar Products You Might Like

The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan
98% match

The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan

£495.00 31 Oct 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
97% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in China

£495.00 07 Nov 2026
Multiple Myeloma Therapeutics in Africa 2013-2018 Outlook
97% match

Multiple Myeloma Therapeutics in Africa 2013-2018 Outlook

£325.00 03 Sep 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan
97% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan

£495.00 05 Nov 2026
World Outlook for Blood Cancer Therapeutics 2025-2030
97% match

World Outlook for Blood Cancer Therapeutics 2025-2030

Price unavailable
World Outlook for Cancer Therapies 2025-2030 Report
97% match

World Outlook for Cancer Therapies 2025-2030 Report

Price unavailable
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics
97% match

The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics

£790.00 29 Oct 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study
97% match

Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study

£520.00 07 Nov 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028
97% match

Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028

£515.00 07 Nov 2026
The 2021-2026 World Outlook for Hematology and Oncology Products
97% match

The 2021-2026 World Outlook for Hematology and Oncology Products

£795.00 05 Nov 2026
The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
97% match

The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

£795.00 13 Sep 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan

£495.00 04 Nov 2026
World Outlook for Cancer Specialty Hospitals 2025-2030
97% match

World Outlook for Cancer Specialty Hospitals 2025-2030

Price unavailable
Chemotherapy and Antibody Therapy Outlook 2023-2028 Report
97% match

Chemotherapy and Antibody Therapy Outlook 2023-2028 Report

£520.00 02 Nov 2026
The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
97% match

The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

£885.00 02 Nov 2026
Chemotherapy and Antibody Therapy Outlook in India 2023-2028
97% match

Chemotherapy and Antibody Therapy Outlook in India 2023-2028

£515.00 07 Nov 2026
World Outlook for Immune-Oncology Treatments 2025-2030
97% match

World Outlook for Immune-Oncology Treatments 2025-2030

£790.00 25 Aug 2026
Cancer Supportive Care Drugs Outlook 2023-2028 Report
97% match

Cancer Supportive Care Drugs Outlook 2023-2028 Report

£520.00 06 Nov 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China
97% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China

£495.00 30 Oct 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 01 Oct 2026
The 2023 Report on Non-Hodgkin Lymphoma Chemotherapy Therapeutics: World Market Segmentation by City
97% match

The 2023 Report on Non-Hodgkin Lymphoma Chemotherapy Therapeutics: World Market Segmentation by City

£795.00 04 Nov 2026
Non-Hodgkin Lymphoma Chemotherapy Market Outlook 2023-2028
97% match

Non-Hodgkin Lymphoma Chemotherapy Market Outlook 2023-2028

£490.00 28 Oct 2026
The 2021-2026 World Outlook for Silent Cancer Therapeutics
97% match

The 2021-2026 World Outlook for Silent Cancer Therapeutics

£795.00 31 Oct 2026
2025-2030 World Outlook for Cancer Biomarkers - ICON Group
97% match

2025-2030 World Outlook for Cancer Biomarkers - ICON Group

Price unavailable